BioTek Instruments has been awarded the LanthaScreen Certified Plus designation from Invitrogen, a provider of essential life science technologies for research, production and diagnostics
The LanthaScreen Certified Plus mark ensures that BioTek's Synergy 4 and Synergy 2 multi-mode microplate readers are validated to strict standards in instrument setup and assay performance.
LanthaScreen technology uses time-resolved fluorescence resonance energy transfer (TR-Fret) to study multiple target classes including protein kinases, nuclear hormone receptors, as well as proteases and ubiquitinated proteins.
BioTek's recently introduced patent-pending Synergy 4 hybrid microplate reader is the first multi-mode reader to combine sensitive filter-based and flexible quadruple monochromator-based fluorescence detection technology in one compact unit.
Using this hybrid technology, customers can now benefit from endless flexibility and true multi-detection for an unlimited number of current and future microplate-based assays.
In addition, Synergy 4 includes fluorescence intensity, luminescence, fluorescence polarization, time-resolved fluorescence, and UV-visible absorbance.
The Synergy 2 multi-mode microplate reader is a modular reader incorporating detection modes for fluorescence intensity, fluorescence polarization, time resolved fluorescence, luminescence and UV-visible absorbance.
Synergy 2 uses a unique combination of monochromator, filters, and dichroic mirrors and three broad-spectrum light sources for optimal illumination that provide the best possible level of performance in all detection modes without performance degradation.
